SEC Form 3 · accession 0000899243-18-020080
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jigar Raythatha
Officer — President and CEO · Director · 10% Owner
Period of report
Jul 18, 2018
Accepted (ET)
Jul 18, 2018 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 14,961 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.51 | holding | — | — | — | — | Jul 10, 2027 | Common Stock | 535,925 | — | D |
| Stock Option (right to buy)F2 | $7.60 | holding | — | — | — | — | Mar 5, 2028 | Common Stock | 141,929 | — | D |
| Stock Option (right to buy)F3 | $8.04 | holding | — | — | — | — | Apr 8, 2028 | Common Stock | 141,929 | — | D |
Explanation of responses
- F1This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the options as of March 20, 2018 with the remainder of the shares vesting in equal quarterly installments through March 20, 2021.
- F2This option was granted on March 6, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through March 6, 2022.
- F3This option was granted on April 9, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through April 9, 2022.
Remarks
Exhibit Index: 24.1 Power of Attorney